NIBEC Co. Ltd (138610) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.024x

Based on the latest financial reports, NIBEC Co. Ltd (138610) has a cash flow conversion efficiency ratio of 0.024x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.13 Billion ≈ $765.98K USD) by net assets (₩47.02 Billion ≈ $31.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 138610 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

NIBEC Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how NIBEC Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NIBEC Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NIBEC Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Baiksan KO:035150	0.077x
Hsinli Chemical Industrial TWO:4303	0.015x
C&C International Corp. KQ:352480	0.045x
Western Forest Products Inc TO:WEF	0.000x
Fino Payments Bank Limited NSE:FINOPB	0.010x
Sammok S-Form Co.Ltd KQ:018310	0.015x
Spruce Biosciences, Inc. Common Stock NASDAQ:SPRB	-0.152x
Whitehawk Therapeutics, Inc. NASDAQ:WHWK	-0.098x

Annual Cash Flow Conversion Efficiency for NIBEC Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of NIBEC Co. Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see NIBEC Co. Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩45.82 Billion ≈ $31.05 Million	₩5.82 Billion ≈ $3.94 Million	0.127x	+1305.36%
2024-12-31	₩32.23 Billion ≈ $21.84 Million	₩291.25 Million ≈ $197.38K	0.009x	+113.30%
2023-12-31	₩28.84 Billion ≈ $19.55 Million	₩-1.96 Billion ≈ $-1.33 Million	-0.068x	-145.98%
2022-12-31	₩36.80 Billion ≈ $24.94 Million	₩5.44 Billion ≈ $3.69 Million	0.148x	+394.14%
2021-12-31	₩27.34 Billion ≈ $18.53 Million	₩817.97 Million ≈ $554.33K	0.030x	+289.86%
2020-12-31	₩31.84 Billion ≈ $21.58 Million	₩-501.66 Million ≈ $-339.97K	-0.016x	+50.23%
2019-12-31	₩27.40 Billion ≈ $18.57 Million	₩-867.62 Million ≈ $-587.97K	-0.032x	+85.49%
2018-12-31	₩10.58 Billion ≈ $7.17 Million	₩-2.31 Billion ≈ $-1.56 Million	-0.218x	-578.82%
2017-12-31	₩12.36 Billion ≈ $8.38 Million	₩563.22 Million ≈ $381.68K	0.046x	+220.46%
2016-12-31	₩9.84 Billion ≈ $6.67 Million	₩-372.21 Million ≈ $-252.24K	-0.038x	+80.82%
2015-12-31	₩10.82 Billion ≈ $7.33 Million	₩-2.13 Billion ≈ $-1.45 Million	-0.197x	-10.83%
2014-12-31	₩5.08 Billion ≈ $3.44 Million	₩-903.85 Million ≈ $-612.53K	-0.178x	--

About NIBEC Co. Ltd

KQ:138610 Korea Biotechnology

Market Cap

$141.54 Million

₩208.86 Billion KRW

Market Cap Rank

#17951 Global

#786 in Korea

Share Price

₩18470.00

Change (1 day)

-5.52%

52-Week Range

₩17430.00 - ₩52300.00

All Time High

₩55200.00